Clinical Trials Browser

Unknown × Brain Neoplasms × tislelizumab × Clear all

NCT05207904 2022-01-26

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Phase 2 Unknown

Brain Neoplasms